Skip to main content

All Articles

CAR T-Cell Therapy Shows “Impressive” Results in Multiple Myeloma

ASH 2017 Highlights, Hematologic Malignancies, Multiple Myeloma

February 2018, Vol 8, No 2

Community Oncology Is Key in Ensuring Access to Cancer Care

By Wayne Kuznar

Practice Management

January 2018, Vol 8, No 1

Community oncology has an important role in eliminating barriers to accessing healthcare and reducing disparities in cancer care. Improving access to high-quality, cost-effective cancer care was addressed from a variety of perspectives at the 2017 Association for Value-Based Cancer Care Summit. Read More ›

Improving Your Cancer Center Operations

By Gail Thompson

Practice Operations

January 2018, Vol 8, No 1

Nivolumab Active in HPV-Positive Gynecologic Cancers

By Charles Bankhead

January 2018, Vol 8, No 1

Beyond Patient Navigation: Expanding Nurses’ Role in Care Coordination

By Gail Thompson

Practice Operations

January 2018, Vol 8, No 1

New Immunotherapies for B-Cell Acute Lymphocytic Leukemia

January 2018, Vol 8, No 1

Immunotherapy: Managing Severe Treatment-Related Toxicities

January 2018, Vol 8, No 1

Select Clinical Trials Currently Enrolling Patients with Leukemia

Clinical Trials Tracker, Leukemia

January 2018, Vol 8, No 1

The Mechanism of Action of CDK4/6 Inhibitors

The Mechanism of Action of CDK4/6 Inhibitors

By Matthew P. Goetz, MD

Breast Cancer, SABCS 2017 Highlights, SABCS Highlights

Dr Matthew Goetz explains the rationale for using CDK4/6 inhibitors in patients with HR-positive metastatic breast cancer. Read More ›

The Use of Chemotherapy in the Metastatic Setting

The Use of Chemotherapy in the Metastatic Setting

By Matthew P. Goetz, MD

SABCS 2017 Highlights, Breast Cancer, SABCS 2017 Highlights, SABCS Highlights

Page 218 of 298